First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT-Reference-Cited by-同舟云学术

First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT

Published:2023-11 Issue: Volume:65 Page:102304
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Saito Shigeru^ORCID,Bennett Johan,Nef Holger M.,Webster Mark,Namiki Atsuo,Takahashi Akihiko,Kakuta Tsunekazu,Yamazaki Seiji,Shibata Yoshisato,Scott Douglas,Vrolix Mathias,Menon Madhav,Möllmann Helge,Werner Nikos,Neylon Antoinette,Mehmedbegovic Zlatko,Smits Pieter C.,Morice Marie-Claude,Verheye Stefan^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. StatPearls [Internet];Chhabra,2023

2. Stent-related adverse events >1 year after percutaneous coronary intervention;Madhavan;J Am Coll Cardiol,2020

3. Neoatherosclerosis and late thrombosis after percutaneous coronary intervention: translational cardiology and comparative medicine from bench to bedside;Borovac;Yale J Biol Med,2017

4. Clinical outcomes before and after complete everolimus-eluting bioresorbable scaffold resorption: five-year follow-up from the ABSORB III trial;Kereiakes;Circulation,2019

5. StatPearls [Internet];Omeh,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent;American Heart Journal;2024-11

2. Clinical Updates in Coronary Artery Disease: A Comprehensive Review;Journal of Clinical Medicine;2024-08-06

3. Platinum chromium everolimus-eluting stents for the treatment of (complex) coronary artery disease; from SYNERGY™ to the MEGATRON™;Expert Review of Medical Devices;2024-05-13

4. Technology viewpoint: Evolution in PCI: The next major advance in implant technology to restore vessel function;Cardiovascular Revascularization Medicine;2023-11